Swiss drugmaker Novartis will sell its entire 70.68% stake in its listed Indian unit to a private equity-led consortium for ...

Swiss pharmaceutical firm Novartis said on Friday that it would sell its entire 70.68% stake in its listed Indian unit to ...

CAMBRIDGE, Mass., Feb. 6, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico") (3696.HK), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced the ...

Shares of Novartis India surged 20% to hit the upper circuit at Rs 996.50 after its Swiss parent, Novartis AG, announced the sale of its entire 70.68% stake in the listed Indian arm for about Rs 1,446 ...

Cambridge, MA., Feb. 6, 2026 — Insilico Medicine (“Insilico”) (3696.HK), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced the appointment of ...

The deal, expected to close by Q3 2026, includes a mandatory open offer for public shareholders at ₹860.64 per share.

Novartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs ...

The Sensex gained 317 pts, or 0.38%, to end at 82,814.7, while the Nifty 50 settled at 25,571.25. up 117 pts, or 0.46%. Barring Nifty IT, all other sectoral indices were trading in the green, led by ...

Tuesday, February 17, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie ...

Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development ...

Following a complete Phase 1 sell-out, Oystra by Richmind Development is attracting UK and international buyers seeking early entry into Ras Al Khaimah's growing coastal market.

Novartis AG to sell its entire 70.68% stake in Novartis India for Rs 1,445.89 crore. Buyers including WaveRise Investments ...